Skip to main content
. 2023 Jan 4;15:11795735221147212. doi: 10.1177/11795735221147212

Table 1.

Characteristics of individuals with regards to clinical outcomes.

MRS ≤ 2 MRS > 2 P Value
N 20 31
Age (median; IQR) 66 (55, 79) 72 (62, 83) P = .120
Gender (Male) 9 (45%) 18 (58.1%) P = .366
NIHSS admission (median; IQR) 6 (6, 12) 13 (6, 27) P < .001
NIHSS discharge (median; IQR) 2 (1,4) 13 (4, 28) P < .001
NIHSS 3 months (median; IQR) 1 (0, 2) 9 (4,28) P < .001
MRS at discharge (median; IQR) 2 (1, 2) 4 (3,5) P < .001
Cardiovascular risk factors
 Diabetes mellitus (%) 4 (20%) 12 (38.7%) P = .164
 Hypertension (%) 13 (65%) 28 (90.3%) P = .028
 Dyslipidemia (%) 11 (55%) 23 (74.2%) P = .160
 Atrial fibrillation (%) 8 (40%) 15 (48.4%) P = .561
 Smoking (%) 6 (30%) 6 (19.4%) P = .386
 Chronic kidney disease (%) 0 2 (6.5%) P = .251
 Illicit drug use (%) 1 (5%) 1 (3.2) P = .752
 Ischemic heart disease (%) 3 (15%) 5 (16.1%) P = .915
Intervention
 Recombinant tissue plasminogen activator (%) 7 (35%) 6 (19.4%) P = .215
 Mechanical thrombectomy (%) 5 (25%) 7 (22.6%) P = .844
Stroke subtype
 Large arterial occlusion (%) 5 (26.3%) 10 (32.3%) P = .582
 Cardioembolic (%) 7 (35%) 16 (51.6%) P = .249
 Small vessel disease (%) 8 (40%) 2 (6.5%) P = .04
 Other determined (%) 0 1 (3.2%) P = .422
 ESUS (%) 0 1 (3.2%) P = .422
Hemorrhagic transformation
 All subtypes (%) 4 (20%) 8 (31.5%) P = .637
 Symptomatic HT 1 (5%) 7 (22.6%) P = .07
 Hemorrhagic infarction 1 (%) 1 (5%) 1 (3.2%) P = .752
 Hemorrhagic infarction 2 (%) 1 (5%) 1 (3.2%) P = .752
 Petechial hemorrhage 1 (%) 1 (5%) 4 (12.9%) P = .359
 Petechial hemorrhage 2 (%) 1 (5%) 2 (6.5%) P = .831
NFL value pg/Ml
 NFL first sample pg/mL (median; IQR) 21.39 (9.28, 44.42) 26.69 (15.10, 64.39) P = .177
 NFL second sample pg/mL (median; IQR) 49.06 (25.22, 65.16) 71.41 (47.58, 153.50) P = .011
 Incremental rate NFL pg/dL × day (median; IQR) 7.12 (1.09,11.93) 24.07 (6.27, 40.30) P = .004

Abbreviation: IQR, interquartile range; NFL, plasma neurofilament light, NIHSS, National Institutes of Health Stroke Scale; mRS, modified rankin score; ESUS, embolic stroke of undetermined source.